Disease subgroups | Datasets | auROC (95% CI) | auPR (95% CI) | Sensitivity | Specificity | PPV | NPV | PLR | NLR |
---|---|---|---|---|---|---|---|---|---|
Age ≥ 65 | Training set (N = 239) | 0.996(0.989–1) | NA | 0.941 | 1.000 | 0.930 | 0.100 | 1.019 | 0.689 |
 | Internal validation set (N = 64) | NA | NA | 1.000 | 1.000 | 0.951 | 0.333 | 1.289 | 0.133 |
 | External validation set (N = 252) | NA | NA | 1.000 | 1.000 | 0.943 | 0.200 | 1.053 | 0.253 |
BMI ≥ 30 | Training set (N = 341) | 0.927(0.904–0.949) | 0.939(0.917–0.96) | 0.824 | 0.874 | 0.708 | 0.691 | 2.122 | 0.390 |
 | Internal validation set (N = 68) | NA | NA | 1.000 | 1.000 | 0.645 | 0.676 | 2.045 | 0.540 |
 | External validation set (N = 213) | 0.971(0.954–0.984) | 0.972(0.954–0.985) | 0.906 | 0.925 | 0.714 | 0.664 | 2.524 | 0.511 |
Dyslipidemia | Training set (N = 3027) | 0.869(0.858–0.879) | 0.866(0.852–0.878) | 0.797 | 0.784 | 0.751 | 0.756 | 3.014 | 0.321 |
 | Internal validation set (N = 754) | 0.922(0.907–0.937) | 0.928(0.911–0.943) | 0.894 | 0.788 | 0.743 | 0.759 | 2.890 | 0.318 |
 | External validation set (N = 2070) | 0.877(0.864–0.888) | 0.877(0.861–0.891) | 0.822 | 0.775 | 0.761 | 0.773 | 3.184 | 0.293 |
Hypertension | Training set (N = 897) | 0.87(0.85–0.89) | 0.945(0.933–0.957) | 0.710 | 0.855 | 0.793 | 0.611 | 1.474 | 0.244 |
 | Internal validation set (N = 235) | 0.978(0.962–0.99) | 0.992(0.985–0.997) | 0.948 | 0.903 | 0.802 | 0.491 | 1.453 | 0.372 |
 | External validation set (N = 658) | 0.895(0.875–0.916) | 0.951(0.939–0.963) | 0.804 | 0.829 | 0.789 | 0.667 | 1.621 | 0.217 |
Diabetes | Training set (N = 241) | 0.973(0.954–0.989) | 0.993(0.986–0.997) | 0.911 | 0.939 | 0.824 | 0.361 | 1.198 | 0.452 |
 | Internal validation set (N = 49) | NA | NA | 1.000 | 1.000 | 0.870 | 0.000 | 0.930 | NA |
 | External validation set (N = 128) | NA | NA | 1.000 | 1.000 | 0.825 | 0.548 | 1.702 | 0.298 |